Desempeño económico de las empresas de base tecnológica en el sector salud humana by Isidre March Chordà, Rosa M. Yagüe Perales, Laura Pérez Ramos

Get full text

A model-based head-to-head comparison of single-agent lurbinectedin in the pivotal ATLANTIS Study by Salvador Fudio, Laura Pérez-Ramos, Eduardo Asín-Prieto, Ali Zeaiter, Rubin Lubomirov

Get full text

Description and Modeling of Relevant Demographic and Laboratory Variables in a Large Oncology Cohort to Generate Virtual Populations by Laura Pérez-Ramos, Laura Ibarra-Gómez, Rubin Lubomirov, María García-Cremades, Eduardo Asín-Prieto, Salvador Fudio, Pablo Zubiaur

Get full text

Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug... by Irene Moreno, Tatiana Hernández, Emiliano Calvo, Salvador Fudio, Carmen Kahatt, Cristian Fernández, Jorge Luis Iglesias, Gema Corral, Laura Pérez-Ramos, Lola Montilla, Ali Zeaiter, Rubin Lubomirov

Get full text

Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug–Drug Interaction Study by Irene Moreno, Tatiana Hernández, Emiliano Calvo, Salvador Fudio, Carmen Kahatt, Sara Martínez, Jorge Luis Iglesias, Román Octavio Calafati, Laura Pérez-Ramos, Lola Montilla, Ali Zeaiter, Rubin Lubomirov

Get full text